Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study

Data on immunogenicity of adenovirus-vectored vaccine in chronic obstructive pulmonary disease (COPD) patients is limited. Therefore, we aimed to determine the humoral and cellular immune responses after homologous ChAdOx-1 vaccination in subjects with COPD. COPD subjects and age- and sex-matched he...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaiwong, Warawut, Takheaw, Nuchjira, Laopajon, Witida, Pata, Supansa, Duangjit, Pilaiporn, Inchai, Juthamas, Pothirat, Chaicharn, Bumroongkit, Chaiwat, Deesomchok, Athavudh, Theerakittikul, Theerakorn, Limsukon, Atikun, Tajarernmuang, Pattraporn, Niyatiwatchanchai, Nutchanok, Trongtrakul, Konlawij, Chuensirikulchai, Kantinan, Cheyasawan, Passaworn, Liwsrisakun, Chalerm, Kasinrerk, Watchara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781239/
https://www.ncbi.nlm.nih.gov/pubmed/36560586
http://dx.doi.org/10.3390/vaccines10122176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781239/
https://www.ncbi.nlm.nih.gov/pubmed/36560586
http://dx.doi.org/10.3390/vaccines10122176

Ejemplares similares